Table 3. Summary of treatment options with lactation
Treatment options |
Comment |
Antipsychotics |
·
No serious side
effects reported ·
Excreted in breast
milk (1/3 of maternal plasma) |
Anticholinergics |
·
Sufficient data not
available |
Antidepressants |
·
Amounts excreted in
breast milk unlikely to harm neonate; no reported long term adverse effects ·
More data supports the
safety of nortriptyline and desipramine in long term usage |
Lithium |
·
Not recommended;
excreted in breast milk (1/2 of maternal plasma); infant’s kidneys cannot
metabolize |
Anxiolytics |
·
Not recommended;
excreted in breast milk; behavioral effects and temperature dysregulation in
infant |
Anticonvulsants |
·
Valproic acid is
compatible with breast feeding (1.2-4% of maternal plasma); no adverse
effects reported ·
Carbamazepine is
“probably safe” as reported by WHO (25-75% of maternal plasma); hepatitis and
hyperbilirubinemia reported |
Calcium-Channel Blockers |
·
Increased risk to
infant heart; long term effects of impotence |
Buspirone |
·
Sufficient data not
available |
published 2000